Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
PT and PTA Clinical Performance Instrument (CPI) 3.0

PT CPI provides a standardized training and assessment tool designed to educate physical therapist students, and other members of physical therapy program academia.

Dismantling the 'Industrial Medical Complex'

Sep 14, 2021/News

The 2021 Maley Lecture was a sobering look at what health care is getting wrong — and a hopeful call for PTs and PTAs to set things right.

Get to Know APTA Home Health: An Interview With Academy President Philip Goldsmith

Dec 10, 2024/Podcast

A brief introduction from the president of the academy.

APTA Academy of Orthopaedic Physical Therapy: Ankle Stability and Movement Coordination Impairments: Lateral Ankle Ligament Sprains Revision

Apr 1, 2021/CPG

Ankle Stability and Movement Coordination Impairments: Ankle Ligament Sprains: Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability and Health From the Orthopaedic Section of the American Physical Therapy Association

Photo Collection: A Look at APTA's Centennial Celebration

Sep 28, 2021/Roundup

We honored our past, thought about our future, and had some good times along the way.

CMS Unveils New, High-Priced Restrictions on Access to Medicare, Medicaid Data

Mar 1, 2024/News

APTA and researchers across the country oppose the new policy, which could have a chilling effect on needed research.

The Year That Can Be

Feb 1, 2015/Column

Where does the time go? Exactly where you direct it.

What Is PTPAC? Five Things You Need to Know

Feb 3, 2023/News

Our political action committee is working on issues that matter now and into the profession's future.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).